NervGen Pharma Corp. (NGEN) income statement
NGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới năm tài chính 2025, năm kết thúc ngày Dec 31, 2025Last filing: 40-F on Mar 31, 2026Score 5/30
$1.90−0.06 (-3.06%)
Close on Nov 18, 2026Market cap $151.33MP/E –Yield –
NervGen Pharma Corp. income statement
Ratios
Latest available, balances at Dec 31, 2025
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- –
Financial strength
- Current ratio
- 1.32
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 127.5%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- –
- Dividend yield
- –
See a number that looks wrong?